The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
Alzheimer's Disease
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
-
Local Institution - 0173, Long Beach, California, United States, 90804
Local Institution - 0008, Redlands, California, United States, 92374
Local Institution - 0025, Basalt, Colorado, United States, 81621
Local Institution - 0024, Washington, District of Columbia, United States, 20007
Local Institution - 0154, Atlantis, Florida, United States, 33462
Local Institution - 0128, Aventura, Florida, United States, 33180
Local Institution - 0023, Merritt Island, Florida, United States, 32952
Local Institution - 0055, Ocala, Florida, United States, 34470
Local Institution - 0263, Stuart, Florida, United States, 34997
Local Institution - 0184, The Villages, Florida, United States, 32162
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
60 Years to 85 Years
ALL
No
Bristol-Myers Squibb,
Bristol-Myers Squibb, STUDY_DIRECTOR, Bristol-Myers Squibb
2029-02-23